Literature DB >> 11186611

Outbreak of Rift Valley fever--Yemen, August-October 2000.

.   

Abstract

On September 17, 2000, the Ministry of Agriculture and Irrigation (MAI) and Ministry of Health (MOH) of Yemen received reports about the occurrence of disease compatible with Rift Valley fever (RVF) in El Zuhrah district of Hodeidah governorate. Reports of animal disease included abortions and deaths in young animals. Surveillance efforts by MOH and MAI documented widespread disease among humans and animals in the area of Wadi Mawr in El Zuhrah district, which is located on a coastal plain that extends from the southern tip of Yemen into the Jizan area of the Kingdom of Saudi Arabia (KSA). The Saudi Arabian Ministry of Health has described a simultaneous outbreak of RVF in the Jizan area in KSA (1,2). This report summarizes the investigation of the Yemen outbreak.

Entities:  

Mesh：

Year:  2000        PMID： 11186611

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  29 in total

1.  Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

3.  Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.

Authors:  Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection.

Authors:  Sonja R Gerrard; Brian H Bird; Cesar G Albariño; Stuart T Nichol
Journal:  Virology       Date:  2006-10-30       Impact factor: 3.616

5.  Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

6.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions.

Authors:  A Desiree LaBeaud; Yoshitsugu Ochiai; C J Peters; Eric M Muchiri; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

8.  Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.

Authors:  Michelle Mendenhall; Min-Hui Wong; Ramona Skirpstunas; John D Morrey; Brian B Gowen
Journal:  Virology       Date:  2009-09-26       Impact factor: 3.616

9.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

10.  Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01.

Authors:  Trevor Shoemaker; Carla Boulianne; Martin J Vincent; Linda Pezzanite; Mohammed M Al-Qahtani; Yagub Al-Mazrou; Ali S Khan; Pierre E Rollin; Robert Swanepoel; Thomas G Ksiazek; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.